| 0 |
CD52-directed Cytolytic Antibody [EPC] |
64 |
0.0033 |
| 1 |
Antiprotozoal [EPC] |
31 |
0.0029 |
| 2 |
Anthelmintic [EPC] |
8 |
0.0028 |
| 3 |
Vitamin D3 Analog [EPC] |
37 |
0.0018 |
| 4 |
Rifamycin Antimycobacterial [EPC] |
4 |
0.0011 |
| 5 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
18 |
0.0008 |
| 6 |
Antimetabolite Immunosuppressant [EPC] |
17 |
0.0008 |
| 7 |
Azole Antifungal [EPC] |
82 |
0.0005 |
| 8 |
Sulfonamide Antibacterial [EPC] |
2 |
0.0005 |
| 9 |
Lipid-based Polyene Antifungal [EPC] |
5 |
0.0004 |
| 10 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
31 |
0.0003 |
| 11 |
Alkylating Drug [EPC] |
77 |
0.0003 |
| 12 |
alpha-Adrenergic Blocker [EPC] |
31 |
0.0002 |
| 13 |
Corticosteroid [EPC] |
254 |
0.0002 |
| 14 |
CD20-directed Cytolytic Antibody [EPC] |
61 |
0.0002 |
| 15 |
Xanthine Oxidase Inhibitor [EPC] |
33 |
0.0002 |
| 16 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
24 |
0.0002 |
| 17 |
CD38-directed Cytolytic Antibody [EPC] |
1 |
0.0002 |
| 18 |
Kinase Inhibitor [EPC] |
94 |
0.0002 |
| 19 |
Antirheumatic Agent [EPC] |
17 |
0.0002 |
| 20 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
7 |
0.0001 |
| 21 |
Polyene Antifungal [EPC] |
5 |
0.0001 |
| 22 |
Cannabinoid [EPC] |
1 |
0.0001 |
| 23 |
Antimycobacterial [EPC] |
3 |
0.0001 |
| 24 |
Echinocandin Antifungal [EPC] |
1 |
0.0001 |
| 25 |
Purine Antimetabolite [EPC] |
11 |
0.0001 |
| 26 |
Erythropoiesis-stimulating Agent [EPC] |
6 |
0.0001 |
| 27 |
Quinolone Antimicrobial [EPC] |
1 |
0.0001 |
| 28 |
beta-Adrenergic Blocker [EPC] |
31 |
0.0001 |
| 29 |
Provitamin D2 Compound [EPC] |
3 |
0.0001 |
| 30 |
CD19-directed Chimeric Antigen Receptor [EPC] |
1 |
0.0001 |
| 31 |
Proteasome Inhibitor [EPC] |
11 |
0.0001 |
| 32 |
Human Immunoglobulin G [EPC] |
2 |
0.0001 |
| 33 |
Topoisomerase Inhibitor [EPC] |
7 |
0.0001 |
| 34 |
Aminoglycoside Antibacterial [EPC] |
4 |
0.0001 |
| 35 |
Insulin [EPC] |
4 |
0.0001 |
| 36 |
Insulin Analog [EPC] |
38 |
0.0001 |
| 37 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
2 |
0.0001 |
| 38 |
Loop Diuretic [EPC] |
38 |
0.0001 |
| 39 |
Folate Analog Metabolic Inhibitor [EPC] |
36 |
0.0001 |
| 40 |
Macrolide Antimicrobial [EPC] |
4 |
0.0001 |
| 41 |
Nucleoside Analog Antiviral [EPC] |
6 |
0.0001 |
| 42 |
Dihydropyridine Calcium Channel Blocker [EPC] |
23 |
0.0001 |
| 43 |
Protease Inhibitor [EPC] |
3 |
0.0001 |
| 44 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
7 |
0.0001 |
| 45 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
2 |
0.0001 |
| 46 |
Nucleoside Metabolic Inhibitor [EPC] |
10 |
0.0000 |
| 47 |
Cytochrome P450 3A Inhibitor [EPC] |
2 |
0.0000 |
| 48 |
Oxazolidinone Antibacterial [EPC] |
1 |
0.0000 |
| 49 |
RANK Ligand Inhibitor [EPC] |
6 |
0.0000 |
| 50 |
Penem Antibacterial [EPC] |
1 |
0.0000 |
| 51 |
Platinum-based Drug [EPC] |
7 |
0.0000 |
| 52 |
Acetylcholine Release Inhibitor [EPC] |
2 |
0.0000 |
| 53 |
Janus Kinase Inhibitor [EPC] |
3 |
0.0000 |
| 54 |
Osmotic Laxative [EPC] |
5 |
0.0000 |
| 55 |
BCL-2 Inhibitor [EPC] |
1 |
0.0000 |
| 56 |
Fluoroquinolone Antibacterial [EPC] |
2 |
0.0000 |
| 57 |
Nitroimidazole Antimicrobial [EPC] |
1 |
0.0000 |
| 58 |
Tetracycline-class Drug [EPC] |
1 |
0.0000 |
| 59 |
Proton Pump Inhibitor [EPC] |
8 |
0.0000 |
| 60 |
Tumor Necrosis Factor Blocker [EPC] |
13 |
0.0000 |
| 61 |
Integrin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 62 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
0.0000 |
| 63 |
Sulfonylurea [EPC] |
1 |
0.0000 |
| 64 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 65 |
Interleukin-6 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 66 |
Microtubule Inhibitor [EPC] |
1 |
0.0000 |
| 67 |
Factor Xa Inhibitor [EPC] |
1 |
0.0000 |
| 68 |
Thalidomide Analog [EPC] |
1 |
0.0000 |
| 69 |
Platelet Aggregation Inhibitor [EPC] |
1 |
0.0000 |
| 70 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
1 |
0.0000 |